about
A functional polymorphism in renalase (Glu37Asp) is associated with cardiac hypertrophy, dysfunction, and ischemia: data from the heart and soul studyPredicting heart failure hospitalization and mortality by quantitative echocardiography: is body surface area the indexing method of choice? The Heart and Soul Study.Usefulness of left atrial volume index to predict heart failure hospitalization and mortality in ambulatory patients with coronary heart disease and comparison to left ventricular ejection fraction (from the Heart and Soul Study).Prognostic value of left ventricular end-systolic volume index as a predictor of heart failure hospitalization in stable coronary artery disease: data from the Heart and Soul Study.C-reactive protein and ischemia in users and nonusers of beta-blockers and statins: data from the Heart and Soul Study.Pulmonary regurgitation end-diastolic gradient is a Doppler marker of cardiac status: data from the Heart and Soul Study.Association of African American race with elevated pulmonary artery diastolic pressure: data from the Heart and Soul Study.Prognostic value of leukocyte telomere length in patients with stable coronary artery disease: data from the Heart and Soul Study.Adiponectin and inducible ischemia in patients with stable coronary heart disease: data from the Heart and Soul study.Increase in end-systolic volume after exercise independently predicts mortality in patients with coronary heart disease: data from the Heart and Soul StudyLeft-ventricular power-to-mass ratio at peak exercise predicts mortality, heart failure, and cardiovascular events in patients with stable coronary artery disease: data from the Heart and Soul Study.Prevalence and prognostic significance of incidental cardiac troponin T elevation in ambulatory patients with stable coronary artery disease: data from the Heart and Soul study.Posttraumatic stress disorder and health-related quality of life in patients with coronary heart disease: findings from the Heart and Soul Study.Relation of beta-blocker use with frequency of hospitalization for heart failure in patients with left ventricular diastolic dysfunction (from the Heart and Soul Study)Resistin, exercise capacity, and inducible ischemia in patients with stable coronary heart disease: data from the Heart and Soul study.Association of resistin with heart failure and mortality in patients with stable coronary heart disease: data from the heart and soul study.A comparison of echocardiography to invasive measurement in the evaluation of pulmonary arterial hypertension in a rat modelThe CHADS2 score predicts ischemic stroke in the absence of atrial fibrillation among subjects with coronary heart disease: data from the Heart and Soul Study.Adiponectin is associated with increased mortality and heart failure in patients with stable ischemic heart disease: data from the Heart and Soul Study.Left atrial function predicts heart failure hospitalization in subjects with preserved ejection fraction and coronary heart disease: longitudinal data from the Heart and Soul StudySix-minute walk test as a prognostic tool in stable coronary heart disease: data from the heart and soul studyPrognostic significance of increased left ventricular mass index to mortality and sudden death in patients with stable coronary heart disease (from the Heart and Soul Study).High-sensitivity cardiac troponin T levels and secondary events in outpatients with coronary heart disease from the Heart and Soul Study.Inducible ischemia and the risk of recurrent cardiovascular events in outpatients with stable coronary heart disease: the heart and soul study.Usefulness of diastolic dominant pulmonary vein flow to predict hospitalization for heart failure and mortality in ambulatory patients with coronary heart disease (from the Heart and Soul Study)Lack of association of chromosome 9p21.3 genotype with cardiovascular structure and function in persons with stable coronary artery disease: The Heart and Soul Study.Development of an echocardiographic risk-stratification index to predict heart failure in patients with stable coronary artery disease: the Heart and Soul study.Elevated pulmonary artery pressure by Doppler echocardiography predicts hospitalization for heart failure and mortality in ambulatory stable coronary artery disease: the Heart and Soul Study.Association of anemia with diastolic dysfunction among patients with coronary artery disease in the Heart and Soul Study.Relation of self-reported angina pectoris to inducible myocardial ischemia in patients with known coronary artery disease: the Heart and Soul Study.Usefulness of noninvasive estimate of pulmonary vascular resistance to predict mortality, heart failure, and adverse cardiovascular events in Patients With stable coronary artery disease (from the Heart and Soul Study).Prevalence and prognosis of asymptomatic left ventricular diastolic dysfunction in ambulatory patients with coronary heart disease.Acute myocardial infarction in patients with versus without aortic valve sclerosis and effect of statin therapy (from the Heart and Soul Study).C-reactive protein, diastolic dysfunction, and risk of heart failure in patients with coronary disease: Heart and Soul Study.Objective evidence of myocardial ischemia in patients with posttraumatic stress disorder.Obtaining accurate hemodynamics from echocardiography: achieving independence from right heart catheterization.Causes and Predictors of Death in Patients With Coronary Heart Disease (from the Heart and Soul Study).Usefulness of an Echocardiographic Composite Cardiac Calcium Score to Predict Death in Patients With Stable Coronary Artery Disease (from the Heart and Soul Study).Prospective validation of an echocardiographic index for determining the severity of chronic mitral regurgitation.Mitral annular calcium, inducible myocardial ischemia, and cardiovascular events in outpatients with coronary heart disease (from the Heart and Soul Study).
P50
Q28748794-447AF6E9-867E-4461-8260-715D4CEA8BDAQ30481065-32123FEE-307D-4035-8335-B51F1E178995Q30484739-04A18E5C-6CA3-42D6-B00B-8052AFF25BC5Q30490011-B5B61730-3DAB-4089-BB65-6DCDD33B6C7AQ30763122-F1EC49B4-9AFA-4AC0-B8D1-39C34B2A087DQ31004049-8D755A03-7959-45EB-9A03-E8E8FF2E330CQ31116704-8BD6E0FD-0D3C-4362-B60A-217B40DDD8CFQ31155030-20D1B62E-866D-48D4-8D95-3E0708B13611Q33396150-D979E074-6DF0-4BCB-8E7D-FDAC55C8E338Q33478347-4A0614A3-77A8-435C-A9D3-FC4960EE30BAQ33492714-B29B312F-D2FC-4F03-ACE8-5A03A55497AFQ33506787-A3CB524D-DEB0-4986-8CF4-E8012D3FE10EQ33657031-3A69DA97-0153-4874-9D5A-FA331C20CD23Q33682749-52CFDA23-B393-403D-BFB5-15C1AC98EB67Q33720243-AFCC2B3D-2482-49A0-9AEB-3C60DD1BCA20Q33780833-3EEA3109-3E76-4A35-B55F-99149A4A74D2Q33843949-1706221A-9A3E-42E7-A16E-294903007AD9Q34008166-87CFCC58-3708-4120-BCE8-CC9A64407820Q34111367-39BBDB07-7999-4F08-98C9-87838C9BA903Q34155579-0035D4C4-16CA-4128-9400-415678BF9C94Q34308313-381641AC-FE51-4862-B983-38B879149871Q36974119-8D53B522-7745-4340-8B60-89A6C392F011Q37036975-491AB355-4B20-4BDE-8D01-2B8E75B83AC2Q37176034-6AF69ADA-3FD0-45F4-AEAB-EFF8600A7DF7Q37187185-AE27D8E2-CA69-4075-A4E3-ECC97C056685Q37279049-B9116EAC-1AE4-4EB8-B948-D592FF7AFFE5Q37388557-527818F5-2D17-4407-B781-CA5F8E20FD94Q37407332-7635FD33-AA8A-48F0-BE22-A13EBFC47A9DQ37419641-BCC5C983-B158-4FA3-8B40-F4E434CCE361Q37419701-5C4011BB-3FB2-4336-BF1A-771C8CDD5B64Q37423324-22346B23-8392-4533-AF56-52F1DED17B23Q37423864-356B28C4-F15A-485F-8B91-F43A2E1218F4Q37423881-CA3F5FF2-2D19-4D21-B11B-4F528D100347Q37462413-6027A913-E263-43C1-99A5-205B9FFA9392Q37733746-81C4CD0A-DF95-4736-A950-EF35597D6298Q37779764-F27ADDAE-096C-4374-ABFC-D744DAAB9603Q38992913-6DD05E5D-BC1A-4654-A223-C8922DEDB8ABQ40951056-0DC9F2A7-D815-478F-9240-42AE6185604BQ44629795-6FAC5760-8072-4AF2-842F-72586603F309Q44745404-EB701F63-8F4E-4433-9C97-CDCA4C39ADE8
P50
name
Nelson B Schiller
@en
type
label
Nelson B Schiller
@en
prefLabel
Nelson B Schiller
@en